SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

Trading Update

19 Oct 2011 07:00

RNS Number : 4400Q
BowLeven Plc
19 October 2011
 

19 October 2011

 

Bowleven plc ("Bowleven" or the "Company")

 

Trading Update

 

The Company will announce its Preliminary Results for the year ended 30 June 2011 on Thursday 3 November. The Company's financial results remain in draft form and are still subject to final approval by the Directors and the auditors before release. A copy of the Preliminary Results announcement will also be made available on the Company's website at www.bowleven.com. The Preliminary Results announcement is expected to include, amongst other things, details of the following:-

·; Resources Update

The Preliminary Results will contain the annual updated contingent resources position (on a net basis) for the Group. The principal movement to the previous year's resources position will be the inclusion of the Sapele Omicron discoveries made during the period. The initial in place volumetrics for these discoveries have already been announced to the market. The range of recovery factors then applied to the volumetrics to derive the resource figures will be in line with the guidance previously provided.

This update will exclude the impact on volumetrics for the net pay intervals encountered in the Sapele-3 well which will be provided in due course.

·; EOV Permit, Gabon

As previously announced, an agreement in principle has been reached with a third party to sell GGPC (EOV) Gabon Limited, the Bowleven Group subsidiary that is the licensee and operator of the EOV Permit. Assets relating to GGPC Gabon (EOV) Limited have been re-classified to assets held-for-sale on the balance sheet in anticipation of the completion of the disposal of this acreage. The assets held for sale figure represents disposal proceeds of US$35 million plus provisional working capital movements since July 2009.

·; Epaemeno Permit, Gabon

The Epaemeno Permit, onshore Gabon has been relinquished following a joint technical review of prospectivity carried out by the Operator, Addax, and Bowleven. This is likely to result in unsuccessful exploration costs of approximately US$42 million being charged to the Income Statement in the financial year ending 30 June 2011 for the write off of the asset. This is a non-cash adjustment.

·; Foreign Exchange Movements (intra Group funding)

The Results for the year will include finance costs which are being charged to the Income Statement of approximately US$23 million, which is primarily occurring from the recognition of foreign exchange movements on intra-group funding under IFRS as the US Dollar weakened against Sterling over the comparative period. This is also a non-cash adjustment.

The financial statements will be prepared on a going concern basis as they anticipate the completion of the proposed placing of shares to be announced today ("the Placing"). Without the additional funding contemplated by the Placing there would be a significant impact on the Company's ability to carry out its proposed 2012 work programme and also to finance its working capital requirements through 2012.

 

As at 31 October 2011, after taking into account all budgeted and approved drilling costs on Sapele-3, but excluding any provision for testing, it is estimated that the Company will have approximately US$15 million in net cash.

 

ENQUIRIES

For further information please contact:

 

Bowleven plc

00 44 131 524 5678

Kevin Hart, Chief Executive

Kerry Crawford, Head of Investor Relations

 

BofA Merrill Lynch (Nomad)

00 44 207 628 1000

Andrew Osborne

Tony White

Brunswick Group LLP

Patrick Handley

Natalia Erikssen

00 44 207 404 5959

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUBDGUSBBGBC
Date   Source Headline
24th Sep 20247:00 amRNSCancellation - BowLeven Plc
20th Sep 20247:00 amRNSHolding(s) in Company
17th Sep 20246:00 pmRNSBowLeven
12th Sep 202410:11 amRNSResult of Exit Opportunity
28th Aug 20242:25 pmRNSResult of GM
9th Aug 20247:00 amRNSCancellation, Exit Opportunity & Notice of GM
22nd Jul 20247:00 amRNSBoard Appointment
30th May 20241:46 pmRNSBlock Admission Update
9th May 20249:52 amRNSBlock Admission Six Monthly Return
9th Apr 20243:43 pmRNSHolding(s) in Company
3rd Apr 202410:35 amRNSResults of Open Offer
2nd Apr 20241:43 pmRNSResult of General Meeting
27th Mar 20247:00 amRNSInterim Results
18th Mar 20247:54 amRNSHolding(s) in Company
15th Mar 20247:00 amRNSStandard form for notification of major holdings
14th Mar 20247:00 amRNSProposed Underwritten Open Offer to raise c$2m
12th Mar 20243:49 pmRNSHolding(s) in Company
25th Jan 202410:59 amRNSTermination of Transaction
6th Dec 20233:43 pmRNSRESULT OF ANNUAL GENERAL MEETING
15th Nov 20235:47 pmRNSPosting of Annual Report and Accounts 2023
10th Nov 20237:00 amRNSFull Year Results
9th Nov 20237:00 amRNSBlock Admission Six Monthly Return
26th Sep 20237:00 amRNSCorporate Update
21st Jul 20237:00 amRNSResponse to Share Price Movement
9th May 20237:00 amRNSBlock Admission Six Monthly Return
30th Mar 20237:00 amRNSInterim Results
25th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 20239:05 amRNSSecond Price Monitoring Extn
25th Jan 20239:00 amRNSPrice Monitoring Extension
1st Dec 202211:48 amRNSRESULT OF ANNUAL GENERAL MEETING
9th Nov 20227:00 amRNSBlock Admission Six Monthly Return
7th Nov 20227:00 amRNSPosting of Annual Report and Accounts 2022
1st Nov 20224:41 pmRNSSecond Price Monitoring Extn
1st Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:30 amRNSFull Year Results
18th Aug 20224:41 pmRNSSecond Price Monitoring Extn
18th Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 202211:05 amRNSSecond Price Monitoring Extn
18th Aug 202211:00 amRNSPrice Monitoring Extension
8th Jul 20227:00 amRNSChange of Partner and Operator at Etinde Licence
13th Jun 20222:05 pmRNSSecond Price Monitoring Extn
13th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 202211:00 amRNSPrice Monitoring Extension
7th Jun 20227:00 amRNSChange of Partner and Operator at Etinde Licence
23rd May 20222:05 pmRNSSecond Price Monitoring Extn
23rd May 20222:00 pmRNSPrice Monitoring Extension
9th May 20228:32 amRNSBlock Admission Six Monthly Review
30th Mar 20227:00 amRNSInterim Results
13th Dec 20212:06 pmRNSSecond Price Monitoring Extn
13th Dec 20212:01 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.